Shares of PTC Therapeutics (PTCT) are down $1.99 to $58.58 in early trading.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTCT:
- PTC Therapeutics participates in a conference call with Truist
- PTC Therapeutics Completes Study on Vatiquinone for Friedreich Ataxia in Young Children
- PTC Therapeutics price target lowered to $71 from $76 at Morgan Stanley
- PTC Therapeutics: Buy Rating Affirmed Amid Temporary Weakness and Promising Pipeline
- JPMorgan adds PTC Therapeutics to Analyst Focus List after selloff